Common Equity: The sum of all common equity items.
Zenas BioPharma, Inc. (ZBIO) had Common Equity of $196.43M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-51.50M |
|
-- |
|
-- |
|
$52.58M |
|
$-52.58M |
|
$1.08M |
|
$-51.50M |
|
$-51.50M |
|
$-51.50M |
|
$-51.50M |
|
$-51.50M |
|
$-51.50M |
|
$-52.58M |
|
$-52.57M |
|
42.16M |
|
42.16M |
|
$-1.22 |
|
$-1.22 |
|
| Balance Sheet Financials | |
$296.64M |
|
$0.05M |
|
$25.38M |
|
$322.02M |
|
$52.42M |
|
$72.99M |
|
$73.17M |
|
$125.59M |
|
|
Common Equity |
$196.43M |
$196.43M |
|
$196.43M |
|
42.21M |
|
| Cash Flow Statement Financials | |
$-119.92M |
|
$-158.52M |
|
$74.44M |
|
$319.83M |
|
$115.56M |
|
$-204.27M |
|
$18.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.66 |
|
-- |
|
-- |
|
0.27 |
|
0.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-119.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-26.22% |
|
-26.22% |
|
-15.99% |
|
-19.11% |
|
$4.65 |
|
$-2.84 |
|
$-2.84 |
|